Sabby Management, Llc

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value
$45.1M
Q ending 2026-03-31
Prior quarter
$69.5M
Q ending 2025-12-31
Change
-35.2% QoQ · +32.7% YoY
Positions
28
reported holdings

Largest positions

All 28 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
HoldingTickerTypeValueShares
Spdr S&P 500 EtfPut$29.1M447
Ishares TrPut$7.4M300
Spdr S&P 500 EtfSPYShares$1.8M3K
Gevo IncPut$1.4M5K
Abivax SaCall$857K77
Alphaton Capital CorpShares$655K2.1M
Briacell Therapeutics CorpBCTXLShares$392K381K
Senestech IncSNESShares$358K219K
Big Tree Cloud Hldgs LtdShares$337K138K
Zevra Therapeutics IncPut$317K340
Briacell Therapeutics CorpBCTXShares$310K74K
Sidus Space IncPut$243K1K
Token Cat LtdTCShares$242K23K
Pop Culture Group Co LtdShares$201K664K
Moleculin Biotech IncMBRXShares$172K75K
Biodexa Pharmaceuticals PlcShares$159K257K
Arcadia Biosciences IncRKDAShares$158K115K
Trx Gold CorpTRXShares$150K100K
Inmed Pharmaceuticals IncINMShares$142K220K
Can Fite Biofarma LtdCANFShares$132K43K
China Sxt Pharmaceuticals IncShares$131K78K
Revelation Biosciences IncREVBShares$119K99K
Calidi Biotherapeutics IncCLDIShares$104K435K
Bluejay Diagnostics IncBJDXShares$53K29K
Lyra Therapeutics IncLYRAShares$51K104K
Tempest Therapeutics IncTPSTShares$29K18K
Briacell Therapeutics CorpBCTXZShares$29K207K
Bnb Plus CorpBNBXShares$9K14K

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.